mitolactol - CISMeF

Preferred Label : mitolactol;

MeSH definition : Alkylating antineoplastic toxic to bone marrow; used in breast cancer, also in combination with other drugs.;

MeSH synonym : dibromodulcitol;

MeSH hyponym : NSC-104800; NSC 104800; NSC104800;

MeSH CAS label : galactitol, 1,6-dibromo-1,6-dideoxy-;

MeSH Related Number : 10318-26-0 (Mitolactol);

Registry Number MeSH : 10318-26-0;

Is substance : O;

UNII : LJ2P1SIK8Y;

InChIKey : VFKZTMPDYBFSTM-GUCUJZIJSA-N;

Détails

Origin ID

D008936;

UMLS CUI

C0026252;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Dibromodulcitol [ICHI extension code]
- Mitolactol [ICHI extension code]
Currated CISMeF NLP mapping
- Mitolactol [ICD-11 Extension code]
- Mitolactol [NCIt concept]
Pharmacological action(s)
- antineoplastic agents, alkylating [MeSH Descriptor]
Record concept(s)
- NSC-104800 [MeSH concept]
- mitolactol [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,2-anhydro-6-bromogalactitol [MeSH Supplementary Concept]
- ADM protocol [MeSH Supplementary Concept]
- BVMM protocol [MeSH Supplementary Concept]
- CD protocol [MeSH Supplementary Concept]
- CDPTH regimen [MeSH Supplementary Concept]
- DAT protocol 2 [MeSH Supplementary Concept]
- DAVH protocol [MeSH Supplementary Concept]
- DAVTH protocol [MeSH Supplementary Concept]
- DAVTHML regimen [MeSH Supplementary Concept]
- DMV protocol [MeSH Supplementary Concept]
- DMV regimen [MeSH Supplementary Concept]
- TPDC-FuHu protocol [MeSH Supplementary Concept]
- TPDCV protocol [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Dibromodulcitol [ICD-11 Extension code]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Mitolactol [ICD-11 Extension code]
- Mitolactol [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients